ThermoGenesis Holdings Overview
- Year Founded
-
1986
- Status
-
Public
- Employees
-
27
- Stock Symbol
-
THMO
- Investments
-
3
ThermoGenesis Holdings General Information
Description
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
Contact Information
Website
www.thermogenesis.comCorporate Office
- 2711 Citrus Road
- Rancho Cordova, CA 95742
- United States
Corporate Office
- 2711 Citrus Road
- Rancho Cordova, CA 95742
- United States
ThermoGenesis Holdings Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 1.7K |
ThermoGenesis Holdings Financials Summary
As of 31-Mar-2024, ThermoGenesis Holdings has a trailing 12-month revenue of $9.6M.
|
In Thousands, USD |
TTM 31-Mar-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 5,233 | 4,879 | 8,495 | 13,803 |
| Revenue | 9,610 | 9,445 | 10,483 | 9,294 |
| EBITDA | (6,943) | (7,740) | (5,270) | (5,144) |
| Net Income | (14,745) | (17,975) | (11,270) | (11,379) |
| Total Assets | 10,087 | 11,232 | 19,386 | 20,652 |
| Total Debt | 6,926 | 10,556 | 10,365 | 10,456 |
ThermoGenesis Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ThermoGenesis Holdings Comparisons
Industry
Financing
Details
ThermoGenesis Holdings Competitors (37)
One of ThermoGenesis Holdings’s 37 competitors is MeiraGTx, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MeiraGTx | Formerly VC-backed | New York, NY | ||||
| Nanobiotix | Formerly VC-backed | Paris, France | ||||
| ToolGen | Formerly VC-backed | Seoul, South Korea | ||||
| Rentschler Biopharma | Venture Capital-Backed | Laupheim, Germany | ||||
| Celyad Oncology | Formerly VC-backed | Mont-Saint-Guibert, Belgium |
ThermoGenesis Holdings Patents
ThermoGenesis Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3913368-A1 | Lateral flow immunoassay test reader and method of use | Inactive | 22-May-2020 | ||
| US-10823746-B1 | Lateral flow immunoassay test reader and method of use | Active | 22-May-2020 | ||
| US-20210364536-A1 | Lateral flow immunoassay test reader and method of use | Inactive | 22-May-2020 | ||
| EP-3844478-A1 | Methods for isolating target cells from blood | Inactive | 31-Aug-2018 | ||
| EP-3844478-A4 | Methods for isolating target cells from blood | Inactive | 31-Aug-2018 | G01N33/56972 |
ThermoGenesis Holdings Signals
ThermoGenesis Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ThermoGenesis Holdings Investments & Acquisitions (3)
ThermoGenesis Holdings’s most recent deal was a Joint Venture with ImmuneCyte Life Sciences. The deal was made on 26-Nov-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ImmuneCyte Life Sciences | 26-Nov-2019 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| SynGen | 07-Jul-2017 | Merger/Acquisition | Other Devices and Supplies | ||
| ThermoGenesis (Acquired 2014) | 19-Feb-2014 | Merger/Acquisition | Therapeutic Devices |
ThermoGenesis Holdings ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
ThermoGenesis Holdings FAQs
-
When was ThermoGenesis Holdings founded?
ThermoGenesis Holdings was founded in 1986.
-
Where is ThermoGenesis Holdings headquartered?
ThermoGenesis Holdings is headquartered in Rancho Cordova, CA.
-
What is the size of ThermoGenesis Holdings?
ThermoGenesis Holdings has 27 total employees.
-
What industry is ThermoGenesis Holdings in?
ThermoGenesis Holdings’s primary industry is Biotechnology.
-
Is ThermoGenesis Holdings a private or public company?
ThermoGenesis Holdings is a Public company.
-
What is ThermoGenesis Holdings’s stock symbol?
The ticker symbol for ThermoGenesis Holdings is THMO.
-
What is ThermoGenesis Holdings’s current revenue?
The trailing twelve month revenue for ThermoGenesis Holdings is $9.6M.
-
Who are ThermoGenesis Holdings’s competitors?
MeiraGTx, Nanobiotix, ToolGen, Rentschler Biopharma, and Celyad Oncology are some of the 37 competitors of ThermoGenesis Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process